Gyala Therapeutics Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$3.33M
- Investors
-
3
Gyala Therapeutics General Information
Description
Developer of cancer therapeutics designed to treat hematological malignancies. The company's therapeutics include a gene therapy that involves modifying the patient's own lymphocytes, a type of white blood cells responsible for immune response, enabling clients in the medical community and patients to combat leukemia and other critical diseases.
Contact Information
Website
www.gyalatx.comCorporate Office
- Cl Paseo De Gracia, 54, 2 D
- Catalonia
- 08012 Barcelona
- Spain
Corporate Office
- Cl Paseo De Gracia, 54, 2 D
- Catalonia
- 08012 Barcelona
- Spain
Gyala Therapeutics Timeline
Gyala Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Later Stage VC | 14-Oct-2024 | $3.33M | Completed | Startup | ||
| 2. Seed Round | 14-Feb-2023 | Completed | Startup | |||
| 1. Seed Round | 26-May-2020 | $1.63M | $1.63M | Completed | Startup |
Gyala Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 68,831 | $0.011084 | $24.13 | $24.13 | 1x | $24.13 | 12.31% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Gyala Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Gyala Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Gyala Therapeutics Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| INNVIERTE SICC | Government | |||
| Nara Capital | Hedge Fund | Minority | ||
| Invivo Partners | Venture Capital | Minority |
Gyala Therapeutics FAQs
-
When was Gyala Therapeutics founded?
Gyala Therapeutics was founded in 2020.
-
Where is Gyala Therapeutics headquartered?
Gyala Therapeutics is headquartered in Barcelona, Spain.
-
What is the size of Gyala Therapeutics?
Gyala Therapeutics has 7 total employees.
-
What industry is Gyala Therapeutics in?
Gyala Therapeutics’s primary industry is Biotechnology.
-
Is Gyala Therapeutics a private or public company?
Gyala Therapeutics is a Private company.
-
What is the current valuation of Gyala Therapeutics?
The current valuation of Gyala Therapeutics is .
-
What is Gyala Therapeutics’s current revenue?
The current revenue for Gyala Therapeutics is .
-
How much funding has Gyala Therapeutics raised over time?
Gyala Therapeutics has raised $6.04M.
-
Who are Gyala Therapeutics’s investors?
INNVIERTE SICC, Nara Capital, and Invivo Partners have invested in Gyala Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
